Analysis of the Risk Factors for Postherpetic Neuralgia
- PMID: 31256167
- DOI: 10.1159/000500482
Analysis of the Risk Factors for Postherpetic Neuralgia
Abstract
Background: Postherpetic neuralgia is the most common complication of herpes zoster, affecting 30% of patients. It seriously affects the quality of life of patients and the curative effect of treatment is limited. So far, researchers do not fully understand the risk factors for postherpetic neuralgia and more research is needed.
Objective: The aim of this paper was to investigate the risk factors for postherpetic neuralgia and provide reference for clinical diagnosis and treatment.
Methods: A total of 202 inpatients with herpes zoster in the General Hospital of Tianjin Medical University were recruited as study subjects. According to the occurrence of postherpetic neuralgia, the patients were divided into the postherpetic neuralgia group and the nonpostherpetic neuralgia group. Data on age, gender, initial symptoms, clinical classification, involved nerves, pain grading, antiviral therapy, glucocorticoid use, and other clinical data of patients in the two groups were collected and statistically analyzed. Univariate and multivariate analysis methods were used to analyze the differences between the two groups and determine the influencing factors of postherpetic neuralgia.
Results: The univariate statistical analysis of the factors influencing postherpetic neuralgia showed that the contribution of gender, initial symptoms, general clinical classification, use of glucocorticoid, and the interval from onset to antiviral therapy were not statistically significant, while the differences in age, specific clinical classification, involved nerves, severity of pain during the acute stage, and body side of skin lesion distribution were statistically significant. Multivariate logistic regression analysis showed that gender, use of glucocorticoid, interval from onset to antiviral therapy, involved nerves, and specific clinical classification showed no statistical significance. However, there were significant differences in age, body side of skin lesion distribution, general clinical classification, and degree of pain during the acute stage of the disease.
Conclusion: Pain during the acute stage of herpes zoster, age greater than 70 years, and serious type of skin lesion are risk factors for postherpetic neuralgia (p < 0.05, OR >1).
Keywords: Logistic regression analysis; Postherpetic neuralgia; Related factors.
© 2019 S. Karger AG, Basel.
Similar articles
-
Analysis of Risk Factors for Postherpetic Neuralgia in Patients With Postmalignancy Herpes Zoster.Pain Physician. 2023 Jul;26(4):E397-E403. Pain Physician. 2023. PMID: 37535787
-
Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.Neurology. 2016 Jul 5;87(1):94-102. doi: 10.1212/WNL.0000000000002808. Epub 2016 Jun 10. Neurology. 2016. PMID: 27287218 Free PMC article.
-
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.J Pain. 2008 Jan;9(1 Suppl 1):S37-44. doi: 10.1016/j.jpain.2007.10.008. J Pain. 2008. PMID: 18166464 Review.
-
The clinical significance of infrared thermography for the prediction of postherpetic neuralgia in acute herpes zoster patients.Skin Res Technol. 2016 Feb;22(1):108-14. doi: 10.1111/srt.12237. Epub 2015 Jun 16. Skin Res Technol. 2016. PMID: 26081167
-
Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options.Dermatol Ther. 2020 Jul;33(4):e13793. doi: 10.1111/dth.13793. Epub 2020 Jul 12. Dermatol Ther. 2020. PMID: 32510833 Review.
Cited by
-
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20. Hum Vaccin Immunother. 2024. PMID: 38767209 Free PMC article.
-
A systematic review and meta-analysis of herpes zoster risk in adults with immunocompromised conditions and autoimmune diseases in Asia-Pacific.Hum Vaccin Immunother. 2025 Dec;21(1):2496048. doi: 10.1080/21645515.2025.2496048. Epub 2025 Apr 29. Hum Vaccin Immunother. 2025. PMID: 40299930 Free PMC article.
-
Efficacy and Safety of Moxibustion for Postherpetic Neuralgia: A Systematic Review and Meta-Analysis.Front Neurol. 2021 Aug 26;12:676525. doi: 10.3389/fneur.2021.676525. eCollection 2021. Front Neurol. 2021. PMID: 34512502 Free PMC article.
-
Efficacy and safety of subcutaneous injection of botulinum toxin in the treatment of Chinese postherpetic neuralgia compared to analgesics: a systematic review of randomized controlled trials and meta-analysis.Front Neurol. 2024 Oct 17;15:1479931. doi: 10.3389/fneur.2024.1479931. eCollection 2024. Front Neurol. 2024. PMID: 39484052 Free PMC article.
-
Effect and safety of extracorporeal shockwave therapy for postherpetic neuralgia: A randomized single-blind clinical study.Front Neurol. 2022 Sep 26;13:948024. doi: 10.3389/fneur.2022.948024. eCollection 2022. Front Neurol. 2022. PMID: 36226089 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical